CCI
OMED

Columbus Circle Investors’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Columbus Circle Investors’s Portfolio OMED Stock Details OMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-253,348
Closed -$5.9M – 326
2014
Q2 		$5.9M Sell
253,348
-443,202
-64% -$10.9M 0.04% 224
2014
Q1 		$23.4M Buy
696,550
+351,057
+102% +$11.8M 0.16% 145
2013
Q4 		$10.2M Buy
+345,493
New +$6.33M 0.07% 214

Other funds holding OMED

SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Columbus Circle Investors's OMED Position: Q3 2014 in Review

Columbus Circle Investors sold out of OncoMed Pharmaceuticals, Inc. (OMED) in Q3 2014, closing a stake of 253,348 shares — an estimated $5.9M sold.

Columbus Circle Investors first reported a position in OMED in Q4 2013 and held it in 3 quarters. The position peaked at $23.4M in Q1 2014. 62 funds tracked by Wall St. Rank hold OMED as of Q3 2014.

  • Columbus Circle Investors reported no remaining OncoMed Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • Columbus Circle Investors sold 253,348 OncoMed Pharmaceuticals, Inc. shares in Q3 2014, an estimated $5.9M.
  • Columbus Circle Investors first reported a position in OncoMed Pharmaceuticals, Inc. in Q4 2013 and held it in 3 quarters.
  • Columbus Circle Investors's OncoMed Pharmaceuticals, Inc. position peaked at $23.4M in Q1 2014.
  • 62 funds tracked by Wall St. Rank held OncoMed Pharmaceuticals, Inc. as of Q3 2014.

Based on Columbus Circle Investors's 13F filing for Q3 2014, filed 5 Nov 2014.